ESC Study Group of Sports Cardiology Recommendations for participation in leisure-time physical activities and competitive sports for patients with hypertension

1 Guidelines Committee. 2003 European Society of Hypertension, European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011–1053. http://www.eshonline.org/documents/2003_guidelines.pdf.

2 McKearney PM Whelton M Reynolds K Muntner P Whelton PK He J . Global burden of hypertension: Analysis of worldwide data. Lancet 2005; 365: 217–223.

3 Verdecchia P . Prognostic value of ambulatory blood pressure: Current evidence and clinical implications. Hypertension 2000; 35: 844–851.

4 Celis H Fagard RH . White-coat hypertension: A clinical review. Eur J Intern Med 2004; 15: 348–357.

5 Kouidi E Fahadidou A Tassoulas E Deligiannis A Coats A . White-coat hypertension detected during screening of male adolescent athletes. Am J Hypertens 1999; 12: 223–226.

6 Björklund K Lind L Zethelius B Andren B Lithell H . Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men. Circulation 2003; 107: 1297–1302.

7 Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903–1913.

8 Fagard RH Celis H . Prognostic significance of various characteristics of out-of-the-office blood pressure. J Hypertens 2004; 22: 1663–1666.

9 Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood pressure-lowering regimens on major cardiovascular events: Results of prospectively designed overviews of randomized trials. Lancet 2003; 362: 1527–1535.

10 EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J 2001; 22: 554–572.

11 Fagard RH Van den Enden M Leeman M Warling X . Survey on treatment of hypertension and implementation of WHO/ISH risk stratification in primary care in Belgium. J Hypertens 2002; 20: 1297–1302.

12 Practice Guidelines Writing Committee. Practice guidelines for primary care physicians: 2003 ESH/ESC Hypertension Guidelines. J Hypertens 2003; 21: 1779–1786. http://www.eshonline.org/documents/2003_hypertension_practice_guidelines.pdf.

13 O'Brien Asmar R Beilin L Imai Y Mallion JM Mancia G , et al. European Society of Hypertension Recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003; 21: 821–848.

14 Deligiannis A . Cardiac side effects of anabolics. Osterr J Sports Med 2002; 2: 35–37.

15 Pope JE Anderson JJ Felson DT . A meta-analysis of the effects of non-steroidal anti-inflammatory drugs on blood pressure. Arch Intern Med 1993; 153: 477–484.

16 Whelton A White WB Bello AE Puma JA Fort JG , SUCCESS-VII Investigators. Effects of celecoxib and rofecoxib on blood pressure and oedema in patients ≧ 65 years of age with systemic hypertension and osteoarthritis. Am J Cardiol 2002; 90: 959–963.

17 De Backer G Ambrosioni E Borck-Johnsen K Brotons C Cifkova R Dallongeville J , et al. European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2003; 24: 1601–1610.

18 Lewis JF Spirito P Pelliccia A Maron BJ . Usefulness of Doppler echocardiographic assessment of diastolic filling in distinguishing ‘athlete's heart’ from hypertrophic cardiomyopathy. Br Heart J 1992; 68: 296–300.

19 Pluim BM Zwindermans AH van der Laarse A van der Wall EE . The athlete's heart. A meta-analysis of cardiac structure and function. Circulation 1999; 100: 336–344.

20 Fagard RH . The athlete's heart. Heart 2003; 89: 1455–1461.

21 Bjørnstad H Smith G Storstein L Meen HD Hals O . Electrocardiographic and echocardiographic findings in top athletes, athletic students and sedentary control subjects. Cardiology 1993; 82: 66–74.

22 Devereux RB Bella J Boman K Gerdts E Nieminen MS Rokkedal J , et al. Echocardiographic left ventricular geometry in hypertensive patients with electrocardiographic left ventricular hypertrophy. The LIFE study. Blood Pressure 2001; 10: 74–82.

23 Maron BJ Roberts WC McAllister HA Rosing DR Epstein SE . Sudden death in young athletes. Circulation 1980; 62: 218–229.

24 Basso C Corrado D Thiene G . Cardiovascular causes of sudden death in young individuals including athletes. Cardiol Rev 1999; 7: 127–135.

25 Corrado D Pelliccia A Bjørnstadt HH Vanhees L Biffi A Borjesson M , et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Eur Heart J 2005; 26: 516–524.

26 Virmani R Burke AP Farb A Kark JA . Causes of sudden death in young and middle-aged competitive athletes. Cardiology Clinics 1997; 15: 439–472.

27 McLenachan JM Henderson E Morris KI Dargie H . Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. NEJM 1987; 317: 787–792.

28 Pelliccia A Fagard R Bjørnstad HH Anastassakis A Arbustini E Assanelli D , et al. Recommendations for competitive sports participation in athletes with cardiovascular disease. A consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology, and the Working Group of Myocardial and Pericardial diseases of the European Society of Cardiology. European Heart Journal; doi: 10.1093/eurheartj/ehi325.

29 Pescatello LS Franklin B Fagard R Farquhar W Kelley GA Ray C . American College of Sports Medicine Position Stand: Exercise and Hypertension. Med Sci Sports Exerc 2004; 36: 533–553.

30 Fagard RH Pardaens K Staessen JA Thijs L . Should exercise blood pressure be measured in clinical practice? J Hypertens 1998; 16: 1215–1217.

31 Fagard R Amery A . Physical exercise in hypertension. In: Laragh J Brenner editors, Hypertension: Pathophysiology, diagnosis and management. Second edition. New York: Raven Press, 1995. pp. 2669–2681.

32 Fagard RH . Physical activity, fitness and blood pressure. In: Bulpitt CJ editor, Handbook of hypertension, Volume 20: Epidemiology of hypertension Amsterdam, The Netherlands: Elsevier Science BV, 2000. pp. 191–211.

33 Fagard RH . Exercise characteristics and the blood pressure response to dynamic physical training. Med Sci Sports Exerc 2001; 33(Suppl): S484–S492.

34 Whelton SP Chin A Xin X He J . Effects of aerobic exercise on blood pressure: A meta-analysis of randomised, controlled trials. Ann Intern Med 2002; 136: 493–503.

35 Cornelissen VA Fagard RH . Effect of resistance training on resting blood pressure: A meta-analysis of randomized controlled trials. J Hypertens 2005; 23: 251–259.

36 Van Baak MA . Hypertension, beta-adrenergic blocking agents and exercise. Int J Sports Med 1994; 15: 112–115.

37 Vanhees L Defoor J Schepers D Lijnen P Peeters BY Lacante PH , et al. Effects of bisoprolol and atenolol on endurance exercise capacity in healthy men. J Hypertens 2000; 18: 35–43.

38 Vanhees L Fagard R Lijnen P Amery A . Effect of antihypertensive medication on endurance exercise capacity in hypertensive sportsmen. J Hypertens 1991; 9: 1063–1068.